Joy Gelfond
Papers
2
Total Citations
34
H-Index
2
About
Joy Gelfond is a clinical researcher whose work centers on prostate cancer outcomes, health-related quality of life (HRQoL), and the real-world impact of treatment decisions in diverse patient populations. Her most notable contribution is a landmark study analyzing HRQoL data from a contemporary, large, and diverse prostate cancer registry, which tracked patient well-being up to 24 months post-treatment. This work, cited over 30 times, provides critical insights into how different therapies affect patients’ physical and emotional health, helping to guide shared decision-making in oncology. Gelfond also investigated the role of urologist experience in the adoption of active surveillance for low-risk prostate cancer, highlighting how provider factors influence treatment patterns. Her research bridges the gap between clinical trial data and everyday practice, emphasizing patient-centered outcomes and health equity. By leveraging large-scale registry data, Gelfond’s work empowers clinicians and patients to make more informed choices, ultimately improving the quality of life for men facing prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2